Paul R Cislo

Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness Analyses.

Demissie Alemayehu, Birol Emir, Paul R Cislo, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma – a flawed analysis?

David C Hoaglin, Paul R Cislo, 2012, Expert opinion on pharmacotherapy.